Clinical Trial Update: Nivolumab and DA-EPOCH-R in Pediatric Primary Mediastinal (Thymic) Large B-cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/2 study is evaluating the combination of nivolumab with the DA-EPOCH-R regimen for pediatric primary mediastinal large B-cell lymphoma, and t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mediastinal Large B-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• Etoposide (Etoposide)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)
• nivolumab (nivolumab)

Snippet

Sponsor: St. Petersburg State Pavlov Medical University | Conditions: Primary Mediastinal (Thymic) Large B-cell Lymphoma, Children | Phase 1, Phase 2 | Status: ENROLLING_BY_INVITATION